When to Order Imaging for Placenta Accreta Spectrum Disorder: ACR Appropriateness Decoded
You are managing a pregnant patient with a history of multiple cesarean sections and a current placenta previa. The concern for Placenta Accreta Spectrum (PAS) disorder is high, and accurate prenatal diagnosis is critical for delivery planning to minimize maternal morbidity. The initial ultrasound was suspicious but not definitive. Do you proceed to Magnetic Resonance Imaging (MRI), and if so, with or without contrast? Or is repeat, specialized ultrasound the better next step? Making the right imaging choice is crucial for patient safety and surgical preparation. This guide decodes the American College of Radiology (ACR) Appropriateness Criteria to help you select the most effective imaging pathway.
What Does ACR Placenta Accreta Spectrum Disorder Cover?
This topic provides imaging recommendations for pregnant patients suspected of having Placenta Accreta Spectrum (PAS) disorder, a condition where the placenta attaches too deeply into the uterine wall. The criteria are stratified based on the patient’s pre-test probability and the clinical scenario, guiding the initial workup and any necessary follow-up imaging. The guidelines specifically address:
- Initial imaging for patients with no known clinical risk factors (low-risk).
- Initial imaging for patients with significant clinical risk factors, such as prior cesarean delivery, placenta previa, or prior uterine surgery.
- Follow-up imaging for patients with an established or highly suspected diagnosis of PAS to aid in delivery planning.
These recommendations are intended for prenatal diagnosis. They do not cover postpartum imaging for retained products of conception or other postpartum complications, which fall under different clinical guidelines. The focus is on identifying the most appropriate non-invasive imaging to assess the depth of placental invasion before delivery.
What Imaging Should I Order for Placenta Accreta Spectrum Disorder? Recommendations by Clinical Scenario
The ACR recommendations for Placenta Accreta Spectrum (PAS) disorder are centered on ultrasound as the primary imaging modality, with MRI reserved for specific problem-solving situations. The choice of study depends heavily on the patient’s risk profile.
For a patient who is at low risk for placenta accreta spectrum disorder with no known clinical risk factors, a standard US pregnant uterus transabdominal is rated Usually appropriate. It is the standard screening examination for placental location and morphology. In this low-risk setting, both US duplex Doppler pregnant uterus and US pregnant uterus transvaginal are considered May be appropriate, typically used to clarify findings from the initial transabdominal scan. MRI, both with and without IV contrast, is Usually not appropriate for these low-risk patients, as the diagnostic yield does not justify the additional resources in the absence of clinical suspicion.
In contrast, for a patient at high risk for placenta accreta spectrum disorder (e.g., history of placenta previa and prior cesarean section), the initial imaging approach is more comprehensive. All three primary ultrasound modalities—US duplex Doppler pregnant uterus, US pregnant uterus transabdominal, and US pregnant uterus transvaginal—are rated Usually appropriate. This multimodal ultrasound approach maximizes the detection of sonographic signs of abnormal placental invasion. If the ultrasound findings are equivocal or if the placenta is posterior, an MRI abdomen and pelvis without IV contrast is rated May be appropriate as a valuable problem-solving tool. However, MRI abdomen and pelvis without and with IV contrast remains Usually not appropriate due to concerns about gadolinium exposure to the fetus.
The recommendations for follow-up of placenta accreta spectrum disorder mirror those for high-risk initial imaging. Once a high suspicion is established, follow-up imaging is often performed to monitor the condition and plan for a complex delivery. Again, US duplex Doppler pregnant uterus, US pregnant uterus transabdominal, and US pregnant uterus transvaginal are all Usually appropriate. An MRI abdomen and pelvis without IV contrast May be appropriate for further anatomical delineation, especially for assessing the extent of potential organ invasion, which is critical for surgical planning. Contrast-enhanced MRI is still Usually not appropriate.
ACR Imaging Recommendations Table
| Clinical Scenario | Top Procedure | ACR Rating | Adult RRL | Pediatric RRL |
|---|---|---|---|---|
| Low risk for placenta accreta spectrum disorder. No known clinical risk factors. Initial Imaging. | US pregnant uterus transabdominal | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| High risk for placenta accreta spectrum disorder. Initial Imaging. | US duplex Doppler / transabdominal / transvaginal pregnant uterus | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| Follow-up of placenta accreta spectrum disorder. | US duplex Doppler / transabdominal / transvaginal pregnant uterus | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
Adult vs. Pediatric Placenta Accreta Spectrum Disorder Imaging: Radiation Dose Tradeoffs
Placenta Accreta Spectrum (PAS) disorder is a condition of the pregnant patient, so the “pediatric” consideration refers to the developing fetus. The ACR guidelines for this topic exclusively recommend imaging modalities with no ionizing radiation: ultrasound and MRI. As indicated by the Relative Radiation Level (RRL) of ‘O 0 mSv’ for all listed procedures, the primary concern is not radiation exposure to the mother or fetus.
The principle of As Low As Reasonably Achievable (ALARA) still applies, but it is interpreted more broadly to include minimizing any potential risk. The main distinction in these guidelines is the consistent “Usually Not Appropriate” rating for MRI with IV contrast. This is due to the fact that gadolinium-based contrast agents cross the placenta and enter the fetal circulation. While no definitive adverse effects have been proven in humans at standard doses, the long-term consequences of fetal exposure are unknown. Therefore, in adherence with safety principles, gadolinium is avoided during pregnancy unless the potential maternal benefit unequivocally outweighs the theoretical fetal risk. For PAS, non-contrast MRI is generally sufficient for problem-solving, making the risk of contrast administration unnecessary.
Imaging Protocol Details for Placenta Accreta Spectrum Disorder
Once you’ve decided on the right study, the protocol matters. A high-quality examination is essential for accurately diagnosing and staging PAS. Our protocol guides cover technique, patient preparation, and key imaging principles for the studies recommended above. For detailed procedural steps, explore the relevant guide:
Tools to Help You Order the Right Study
Selecting the correct imaging study from a list of options is only the first step. GigHz offers a suite of reference tools to support clinical decision-making from order entry to final report.
For clinical questions beyond Placenta Accreta Spectrum Disorder, the ACR Appropriateness Criteria Lookup tool provides comprehensive, scenario-based guidance across all specialties. It helps you quickly find the ACR’s official recommendations for thousands of clinical presentations.
To ensure the chosen study is performed correctly, the Imaging Protocol Library offers detailed, step-by-step protocols for a wide range of CT, MRI, and ultrasound examinations. These guides are essential for standardizing image acquisition and ensuring diagnostic quality.
When discussing imaging options with patients, especially those involving any potential exposure, the Radiation Dose Calculator is a valuable resource. It helps estimate cumulative radiation dose and provides clear, patient-friendly explanations of radiation risk.
What are the key ultrasound findings for placenta accreta spectrum?
Key gray-scale ultrasound findings include loss of the normal hypoechoic retroplacental “clear space,” thinning of the myometrium overlying the placenta to less than 1 mm, and the presence of placental lacunae (irregular vascular spaces within the placenta). Color Doppler may show turbulent flow within the lacunae and vessels bridging from the placenta across the myometrium into the bladder or surrounding tissues.
Why is MRI with contrast “Usually Not Appropriate” for placenta accreta spectrum?
Gadolinium-based contrast agents cross the placenta and enter fetal circulation. The contrast is then excreted by the fetal kidneys into the amniotic fluid and subsequently swallowed, leading to prolonged exposure. While there is no definitive evidence of harm to the human fetus from standard clinical doses, the long-term effects are unknown. Given that non-contrast MRI can typically provide the necessary diagnostic information for PAS, the ACR recommends avoiding the theoretical risk of gadolinium exposure to the fetus.
When should I order an MRI for suspected placenta accreta spectrum?
MRI is not a first-line imaging tool for PAS but serves as a problem-solving modality. According to the ACR, a non-contrast MRI of the abdomen and pelvis “May be appropriate” in high-risk patients or for follow-up when ultrasound findings are equivocal or inconclusive. It is particularly useful for evaluating a posterior placenta, which can be difficult to assess with ultrasound, and for delineating the extent of invasion into adjacent organs like the bladder, which is critical information for surgical planning.
What are the primary risk factors for placenta accreta spectrum?
The most significant risk factor is a history of prior cesarean delivery, especially when combined with a current placenta previa. The risk increases with the number of prior cesarean sections. Other risk factors include any prior uterine surgery (such as myomectomy), advanced maternal age, and a history of Asherman syndrome (intrauterine adhesions).
Is transvaginal ultrasound safe in a patient with placenta previa?
Yes, when performed correctly, transvaginal ultrasound is considered safe in patients with placenta previa. The probe is inserted carefully into the vaginal fornix and does not need to touch the cervix. It often provides a clearer view of the lower uterine segment and the relationship between the placental edge and the internal cervical os compared to transabdominal ultrasound. It is a standard and valuable component of the evaluation for both placenta previa and accreta spectrum disorders.
Frequently Asked Questions
What are the key ultrasound findings for placenta accreta spectrum?
Key gray-scale ultrasound findings include loss of the normal hypoechoic retroplacental “clear space,” thinning of the myometrium overlying the placenta to less than 1 mm, and the presence of placental lacunae (irregular vascular spaces within the placenta). Color Doppler may show turbulent flow within the lacunae and vessels bridging from the placenta across the myometrium into the bladder or surrounding tissues.
Why is MRI with contrast “Usually Not Appropriate” for placenta accreta spectrum?
Gadolinium-based contrast agents cross the placenta and enter fetal circulation. The contrast is then excreted by the fetal kidneys into the amniotic fluid and subsequently swallowed, leading to prolonged exposure. While there is no definitive evidence of harm to the human fetus from standard clinical doses, the long-term effects are unknown. Given that non-contrast MRI can typically provide the necessary diagnostic information for PAS, the ACR recommends avoiding the theoretical risk of gadolinium exposure to the fetus.
When should I order an MRI for suspected placenta accreta spectrum?
MRI is not a first-line imaging tool for PAS but serves as a problem-solving modality. According to the ACR, a non-contrast MRI of the abdomen and pelvis “May be appropriate” in high-risk patients or for follow-up when ultrasound findings are equivocal or inconclusive. It is particularly useful for evaluating a posterior placenta, which can be difficult to assess with ultrasound, and for delineating the extent of invasion into adjacent organs like the bladder, which is critical information for surgical planning.
What are the primary risk factors for placenta accreta spectrum?
The most significant risk factor is a history of prior cesarean delivery, especially when combined with a current placenta previa. The risk increases with the number of prior cesarean sections. Other risk factors include any prior uterine surgery (such as myomectomy), advanced maternal age, and a history of Asherman syndrome (intrauterine adhesions).
Is transvaginal ultrasound safe in a patient with placenta previa?
Yes, when performed correctly, transvaginal ultrasound is considered safe in patients with placenta previa. The probe is inserted carefully into the vaginal fornix and does not need to touch the cervix. It often provides a clearer view of the lower uterine segment and the relationship between the placental edge and the internal cervical os compared to transabdominal ultrasound. It is a standard and valuable component of the evaluation for both placenta previa and accreta spectrum disorders.
Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 21, 2026
